VerixAi Reviews & Product Details

CorMetrix develops VerixAi, the clinical evidence engine for healthcare quality and oversight. VerixAi turns complex medical records into source-linked clinical evidence, helping reviewers reconstruct the clinical course and examine the care it describes. Its first commercial application is medical malpractice and personal injury litigation, supporting law firms, legal nurse consultants, and medical experts. Reviewers can create chronologies, identify record gaps and inconsistencies, ask questions across the record, and verify findings against the original source pages. The underlying evidence layer is designed to support broader applications in healthcare quality review, peer review, coverage and claims, and oversight. Product development began in late 2023, the first funding round occurred in 2024, and VerixAi launched commercially in June 2026.